Skip to main content
    S

    Sutro Biopharma (STRO)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $9.32
    -0.50 (-5.09%)

    Market Cap: $163.03M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Sutro Biopharma (STRO) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to Sutro Biopharma are Sionna Therapeutics, Inc. Common Stock (SION), Palisade Bio (PALI) and Upstream Bio (UPB). By market cap, Sutro Biopharma ranks 7th of the 13 companies on this page; Precision BioSciences (DTIL) is the largest at $288.76M.

    Peer Comparison

    STRO's revenue growth of -6.1% is below the peer median of 0.0%. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Sutro Biopharma (STRO)$163.03MN/A3.4x0.0%N/A-6.1%0.00%
    Sionna Therapeutics, Inc. Common Stock (SION)$150.63MN/AN/A0.0%N/A0.0%0.00%
    Palisade Bio Inc (PALI)$201.01MN/A436.8x0.0%N/A0.0%0.00%
    Upstream Bio, Inc. (UPB)$152.38MN/A41.0x0.0%N/A-42.2%0.00%
    Cartesian Therapeutics Inc. (RNAC)$193.69MN/A179.8x0.0%147.2%-92.9%0.00%
    SAB Biotherapeutics Inc (SABS)$266.66MN/AN/A0.0%N/A-62.4%0.00%
    Bright Minds Biosciences Inc (DRUG)$227.96MN/AN/A0.0%-11.2%0.0%0.00%
    Fate Therapeutics Inc (FATE)$155.74MN/A29.7x0.0%-51.3%9.2%0.00%
    Codexis Inc (CDXS)$127.13MN/AN/A-21.8%N/A124.0%0.00%
    Compass Therapeutics Inc. (CMPX)$139.35MN/AN/A0.0%N/A0.0%0.00%
    PDS Biotechnology Corp (PDSB)$107.07MN/AN/A0.0%-149.8%0.0%0.00%
    Greenwich Lifesciences Inc (GLSI)$219.29MN/AN/A0.0%N/A0.0%0.00%
    Precision BioSciences Inc (DTIL)$288.76MN/A4.4x-85.6%-38.3%37272.0%0.00%
    Peer median$174.72MN/A41.0x0.0%-38.3%0.0%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to Sutro Biopharma, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.

    CompanyAboutPeers
    Sionna Therapeutics, Inc. Common Stock (SION)
    Sionna Therapeutics, Inc. is an innovative biotechnology company focused on developing advanced therapies for neurodegenerative disorders...
    SION competitors
    Palisade Bio Inc (PALI)
    Leading BioSciences, Inc. develops therapies to improve human health through therapeutic protection of the gastrointestinal mucosal barrier.
    PALI competitors
    Upstream Bio, Inc. (UPB)
    Upstream Bio, Inc., a clinical-stage biotechnology company, develops treatments for inflammatory diseases that focuses on severe respiratory disorders.
    UPB competitors
    Cartesian Therapeutics Inc. (RNAC)
    Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of nanoparticle immunomodulatory drugs...
    RNAC competitors
    SAB Biotherapeutics Inc (SABS)
    SAB Biotherapeutics, Inc., a biopharmaceutical company, develops immunotherapies against infectious diseases, autoimmune diseases, and oncology.
    SABS competitors
    Bright Minds Biosciences Inc (DRUG)
    Bright Minds Biosciences Inc. (DRUG) is a forward-thinking clinical-stage biotechnology firm specializing in the development of groundbreaking therapies...
    DRUG competitors
    Fate Therapeutics Inc (FATE)
    Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders globally.
    FATE competitors
    Codexis Inc (CDXS)
    Codexis, Inc. discovers, develops and sells biocatalysts. The company is headquartered in Redwood City, California.
    CDXS competitors
    Compass Therapeutics Inc. (CMPX)
    Compass Therapeutics, Inc. is a clinical-stage oncology-focused biopharmaceutical company developing proprietary antibody-based therapies to treat multiple...
    CMPX competitors
    PDS Biotechnology Corp (PDSB)
    PDS Biotechnology Corporation, a clinical-phase biopharmaceutical company, is focused on developing multifunctional cancer immunotherapies.
    PDSB competitors
    Greenwich Lifesciences Inc (GLSI)
    Greenwich LifeSciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development of new cancer immunotherapies for breast and other HER2 /...
    GLSI competitors
    Precision BioSciences Inc (DTIL)
    Precision BioSciences, Inc., a genome editing company, develops therapeutic products in the United States.
    DTIL competitors

    Frequently Asked Questions About STRO

    Who are Sutro Biopharma's main competitors?

    The companies most similar to Sutro Biopharma include Sionna Therapeutics, Inc. Common Stock (SION), Palisade Bio (PALI), Upstream Bio (UPB), Cartesian Therapeutics (RNAC) and SAB Biotherapeutics (SABS), listed from the closest match.

    Who is Sutro Biopharma's biggest competitor?

    Precision BioSciences (DTIL) is the largest of the similar companies at $288.76M; Sionna Therapeutics, Inc. Common Stock (SION) is the closest match by business profile, size, sector and industry.

    How does STRO stock compare with its competitors?

    STRO's P/S is 3.4x against a peer median of 41.0x; its net margin is 0.0% against a peer median of 0.0%.

    Which of Sutro Biopharma's competitors pays a higher dividend?

    Sutro Biopharma pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.

    Is Sutro Biopharma bigger than its competitors?

    No. Sutro Biopharma is 7th by market cap among the 13 companies on this page; the largest is Precision BioSciences (DTIL) at $288.76M.